Martin Wienkenhöver

16.03.2015 • News

CABB names new CEO: Peter Vanacker to succeed Martin Wienkenhöver

Effective April 1, 2015, Peter Vanacker will succeed Dr. Martin Wienkenhöver as CEO of CABB, a leading global fine chemicals manufacturer.

Top-Feature

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CABB Group GmbH